Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In the Search for Photocages Cleavable with Visible Light: An Overview of Recent Advances and Chemical Strategies

  • Josa-Culleré, Laia
  • Llebaria, Amadeu
Photopharmacological tools enable the precise spatiotemporal control of small molecule drugs. Amongst them, caged compounds incorporate a photolabile moiety which is released under illumination, thus liberating the active molecule. Caging groups have long been known and many chemical scaffolds have already been used in different applications. However, most of the initial examples are cleaved with UV light, which suffers from low tissue permeability and cell damage. Recently, caging groups that are released under visible light have been reported, which expand their utility. In this review, we outline the chemical strategies that have been used to increase the absorption wavelengths; we compare their photophysical properties, discuss their synthetic accessibility, and exemplify some of their biological applications., Dr L. Josa‐Culleré has received funding from the European Union's Horizon2020 research and innovation programme under the Marie Sklodowska‐Curie grant agreement No 841089. Dr. A. Llebaria is supported by Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación and ERDF‐FEDER European Fund (project CTQ2017‐89222‐R, PCI2018‐093047) and by the Catalan government (2017 SGR 1604)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Visible-Light-Controlled Histone Deacetylase Inhibitors for Targeted Cancer Therapy

  • Josa-Culleré, Laia
  • Llebaria, Amadeu
The lack of selectivity of anticancer drugs limits current chemotherapy. Light-activatable drugs, whose activity can be precisely controlled with external light, could provide a more localized action of the drugs in the tumor, thus decreasing side effects and increasing efficacy. Herein, we introduce a series of photoswitchable azobenzene histone deacetylase inhibitors (HDACis) whose activity can be controlled by external visible light. Initial HDACis isomerized under ultraviolet light and were up to >50-fold more active under illumination than in the dark in enzyme assays. These were then optimized toward compounds responding to more permeable and less harmful green light by introducing o-halogen atoms into the azobenzene. Selected compounds decreased cell viability only under illumination in four different cancer cell lines. Overall, we present photoswitchable HDACis with optimized activation wavelengths, which inhibit enzyme activity and cell viability only upon illumination with visible light, contributing to the still limited toolbox of photoswitchable anticancer drugs., L.J.-C. has received funding from the European Union’s Horizon2020 research and innovation programme under Marie Sklodowska-Curie Grant Agreement 841089. A.L. received funding from Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación 10.13039/501100011033 and ERDF A way of making Europe (Projects I+D+i CTQ2017-89222-R and PID2020-120499RB-I00), and the Catalan government (2017 SGR 1604). The authors thank Dr. Lourdes Muñoz from SimChem (IQAC-CSIC) for analytical and instrumental support. The authors thank Dr. Wiktor Szymanski (University of Groningen, Groningen, The Netherlands) for helpful discussions., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hemithioindigo-based histone deacetylase inhibitors induce a light-dependent anticancer effect

  • Josa-Culleré, Laia
  • Aira Rodríguez, Carla
  • Llebaria, Amadeu
Photoswitchable molecules exhibit light-dependent biological activity which allow us to control the therapeutic effect of drugs with high precision. Such molecules could solve some of the limitations of anticancer drugs by providing a localised effect in the tumour. Histone deacetylase inhibitors (HDACis) constitute a promising drug class for oncology whose application is often limited by a lack of selectivity. Herein, we developed photoswitchable HDACis based on a hemithioindigo scaffold. We established synthetic routes to access them and determined the optimal conditions for isomerisation and their thermal stability. We then optimised their enzyme activity through three rounds of re-design to identify examples that are up to 6-fold more active under illumination than in the dark. We also confirmed that our best derivative reduces the viability of HeLa cells only under illumination. All in all, we disclose a series of derivatives containing a hemithioindigo moiety, which display a light-dependent effect on both HDAC inhibition and cancer cell viability., L.J.-C. has received funding from the European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant Agreement 841089 and from grant IJC2020-043482-I funded by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. C.A.R. received funding from a fellowship of the CSIC JAE Intro 2021 program (JAEINT21_EX_ 1165). A.L. received funding from Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación 10.13039/501100011033 and ERDF A way of making Europe (Projects I + D + i CTQ2017-89222-R and PID2020-120499RB-I00), and the Catalan government (2021 SGR 00508). The authors thank Lourdes Muñoz from SimChem (IQAC-CSIC) and Yolanda Pérez from the NMR service for analytical and instrumental support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

[Dataset] Hemithioindigo-based histone deacetylase inhibitors induce a light-dependent anticancer effect

  • Josa-Culleré, Laia
  • Aira Rodríguez, Carla
  • Llebaria, Amadeu
Photoswitchable molecules exhibit light-dependent biological activity which allow us to control the therapeutic effect of drugs with high precision. Such molecules could solve some of the limitations of anticancer drugs by providing a localised effect in the tumour. Histone deacetylase inhibitors (HDACis) constitute a promising drug class for oncology whose application is often limited by a lack of selectivity. Herein, we developed photoswitchable HDACis based on a hemithioindigo scaffold. We established synthetic routes to access them and determined the optimal conditions for isomerisation and their thermal stability. We then optimised their enzyme activity through three rounds of re-design to identify examples that are up to 6-fold more active under illumination than in the dark. We also confirmed that our best derivative reduces the viability of HeLa cells only under illumination. All in all, we disclose a series of derivatives containing a hemithioindigo moiety, which display a light-dependent effect on both HDAC inhibition and cancer cell viability., L.J.-C. has received funding from the European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant Agreement 841089 and from grant IJC2020-043482-I funded by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. C.A.R. received funding from a fellowship of the CSIC JAE Intro 2021 program (JAEINT21_EX_ 1165). A.L. received funding from Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación 10.13039/501100011033 and ERDF A way of making Europe (Projects I + D + i CTQ2017-89222-R and PID2020-120499RB-I00), and the Catalan government (2021 SGR 00508). The authors thank Lourdes Muñoz from SimChem (IQAC-CSIC) and Yolanda Pérez from the NMR service for analytical and instrumental support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

[Dataset] Visible-Light-Controlled Histone Deacetylase Inhibitors for Targeted Cancer Therapy

  • Josa-Culleré, Laia
  • Llebaria, Amadeu
1H and 13C NMR spectra, HPLC traces, and full photochemical characterization of the final compounds (PDF) Molecular formula strings (CSV), The lack of selectivity of anticancer drugs limits current chemotherapy. Light-activatable drugs, whose activity can be precisely controlled with external light, could provide a more localized action of the drugs in the tumor, thus decreasing side effects and increasing efficacy. Herein, we introduce a series of photoswitchable azobenzene histone deacetylase inhibitors (HDACis) whose activity can be controlled by external visible light. Initial HDACis isomerized under ultraviolet light and were up to >50-fold more active under illumination than in the dark in enzyme assays. These were then optimized toward compounds responding to more permeable and less harmful green light by introducing o-halogen atoms into the azobenzene. Selected compounds decreased cell viability only under illumination in four different cancer cell lines. Overall, we present photoswitchable HDACis with optimized activation wavelengths, which inhibit enzyme activity and cell viability only upon illumination with visible light, contributing to the still limited toolbox of photoswitchable anticancer drugs., L.J.-C. has received funding from the European Union’s Horizon2020 research and innovation programme under Marie Sklodowska-Curie Grant Agreement 841089. A.L. received funding from Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación 10.13039/501100011033 and ERDF A way of making Europe (Projects I+D+i CTQ2017-89222-R and PID2020-120499RB-I00), and the Catalan government (2017 SGR 1604). The authors thank Dr. Lourdes Muñoz from SimChem (IQAC-CSIC) for analytical and instrumental support. The authors thank Dr. Wiktor Szymanski (University of Groningen, Groningen, The Netherlands) for helpful discussions., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Photocaged Chloroquine Derivatives for the Light-Dependent Inhibition of Autophagy in Cancer Stem Cells

  • Alonso-Manresa, Sofía
  • Serra, Carme
  • Muñoz, Lourdes
  • Bataller, Marina
  • Garcia-Mayea, Yoelsis
  • Lleonart Pajarin, Matilde Esther
  • Garcia Prats, Belen
  • Mancilla Zamora, Sandra
  • Diaz Riascos, Zamira Vanessa
  • Llebaria, Amadeu
  • Josa-Culleré, Laia
Chloroquine (CQ) and hydroxychloroquine (HCQ) inhibit autophagy and have shown promise as adjuvant anticancer agents, particularly for targeting therapy-resistant cancer stem cells (CSCs). However, their clinical utility is limited by systemic toxicity and poor tumor selectivity. Here, we report the design, synthesis, and photochemical evaluation of [7-(diethylamino)coumarin-4-yl]methyl (DEACM)-caged CQ and HCQ derivatives as visible-light-activated autophagy inhibitors. Selective caging of the aliphatic amine suppressed biological activity in the dark and enabled rapid release of the parent drugs upon illumination. The lead compound 1C displayed robust light-dependent cytotoxicity across multiple cancer cell lines and, upon photoactivation, recapitulated CQ's effects on LC3-II accumulation. In CSC-enriched tumorspheres, 1C completely abolished sphere formation only if illuminated. Ex vivo and in vivo studies confirmed that visible light penetrates tumor tissue sufficiently to activate 1C and locally release CQ within the tumor. These findings establish the first proof of concept for light-controlled autophagy inhibition and provide a blueprint for spatiotemporally confined anticancer therapies based on photopharmacological modulation of CSCs., L.J.-C. has received funding from the European Union’s Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant Agreement 841089 and from grants IJC2020-043482-I and RyC2023-042477-I funded by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. S.A.M. received funding from a fellowship of the CSIC JAE Intro ICU 2024 program (JAEICU_24_00882). M.E.LL. has received funding from the FIS project PI24/00630. The UPLC analyses from the in vivo studies were done by the Innopharma platform from University of Santiago de Compostela. The authors thank Gemma Fabrias, Mireia Casasampere, and Tania Roda from the Research Unit on BioActive Molecules for support with the Western Blot studies, Yolanda Pérez from the NMR service for analytical and instrumental support, and Elisabet Perez Albadalejo, Jorge Gandia, and Xavier Rovira for biological support., Peer reviewed